All topics / Medications

Medication classes

IL-23 inhibitor

IL-23 inhibitor articles covering treatments such as risankizumab and other therapy updates relevant to Crohn's disease and IBD.

Page 3 of 3 · 98 articles

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
finance.yahoo.com

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
Medications Mirikizumab IL-23 inhibitor Crohn's disease Ulcerative colitis

This expands U.S. treatment options: Omvoh (mirikizumab) is now FDA‑approved for both major forms of IBD (ulcerative colitis and Crohn's disease), which may matter for people who haven’t responded to other therapies. The...

Read Summary